POTASSIUM CITRATE
Generic: POTASSIUM CITRATE
Camber PharmaceuticalsManufacturer
ORALRoute
POTASSIUM CITRATEActive Substance
2021-02-05Original Approval
POTASSIUM CITRATE is FDA application ANDA214420, sponsored by ASCENT PHARMS INC. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Class II2018-07-18
Potassium Citrate Extended-Release Tablets, USP, 10 mEq, 100-count bottles, Rx only, Manufactured for: Vensun PharmaceutFailed Tablet/Capsule Specifications: Tablet breakage
Class II2018-07-18
Potassium Citrate Extended-Release Tablets, USP, 15 mEq, 100-count bottles, Rx only, Manufactured for: Vensun PharmaceutFailed Tablet/Capsule Specifications: Tablet breakage
Top Reported Reactions
1
DRUG INEFFECTIVE
417 reports
2
FATIGUE
341 reports
3
DIARRHOEA
309 reports
4
NAUSEA
298 reports
5
PAIN
287 reports
6
OFF LABEL USE
247 reports
7
NEPHROLITHIASIS
245 reports
8
DIZZINESS
219 reports
9
DYSPNOEA
211 reports
10
HEADACHE
197 reports